Arkolith/Insider Trading/BNKL/Form 4

Auberton-Herve Andre-Jacques

DirectorBionik Laboratories Corp. (BNKL) · full profile →Form 4 · filed Jun 21, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 15, 2021Option exercise(M)52K$3.60$187K276K
Jul 15, 2021Option exercise(M)8K$3.16$24K284K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 15, 2021Option exercise(M)8K—$00
Jul 15, 2021Option exercise(M)52K—$064K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-073086) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML